Kidney drug avacopan tested in dialysis patients – no major breakthrough yet
NCT ID NCT06468826
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 24 times
Summary
This study looked at how the drug avacopan is processed in people with normal kidneys and those with end-stage kidney disease who need dialysis. A single dose was given to 13 adults, and researchers measured drug levels in the blood and dialysis fluid. The goal was to understand safety and how dialysis affects the drug, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Floridian Clinical Research, LLC
Miami Lakes, Florida, 33016, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809-3017, United States
Conditions
Explore the condition pages connected to this study.